Aneurysm
Study data from M.M. Berger and colleagues update understanding of aneurysm
Published in Medical Device Law Weekly, November 9th, 2008
"Intervention consisted in 4 days of either standard ( STD: Lipofundin medium-chain triglyceride (MCT): long-chain triglyceride (LCT)50%-MCT50%) or FO containing PN (FO: Lipoplus: LCT40%-MCT50%-FO10%). Energy target were set at 1.3 times the preoperative resting energy expenditure by indirect calorimetry. Blood sampling on days 0, 2, 3 and 4. Glucose turnover by the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Anti-Infectives
Nektar Sells Pulmonary Business to Novartis for $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder - Breast Cancer
Metropolitan Chicago Breast Cancer Task Force Reports on Progress Toward Reducing the Black-White Disparity in Breast Cancer Mortality and Improving Breast Health for All Women - Cardiology
Jacc Intervention Publishes Mivs Vestasync I Trial Preliminary Results - Glancy Binkow & Goldberg Llp
Glancy Binkow & Goldberg LLP, Representing Shareholders of the Spectranetics Corporation, Announces an Expanded Class Period in the Shareholder Lawsuit - Memento, Inc.
Memento and IBM Join Forces to Help Financial Institutions Fight Fraud - NuVasive, Inc.
Nuvasive Reports Third Quarter 2008 Financial Results - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
